BNET Industries

Market Cap:$149.2B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Pfizer and B.C. launch $9M collaboration to tackle cancer
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Pfizer signs agreement with Protalix BioTherapeutics for Taliglucerase alfa
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Roche's Merger Formula for Genentech
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
Pfizer Inc. and Wyeth; Analysis of Agreement Containing Consent Order To Aid Public Comment and...
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
-
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24
-
ImmunoVaccine signs exclusive licence deal with Pfizer
-
Pfizer Animal Health selects Bader Rutter as agency of record
-
FDA panel backs Pfizer's anti-infection vaccine for kids
-
Cash Just Kept On Piling Up, But It Looks Like The Spending Has Started
-
Goldman Sachs Said Pfizer PFE Best Positioned US Pharma in China
News & Analysis
Filter by
pfizer inc. and viagra - All News and Analysis
Pfizer's Viagra Shows Signs of Flagging: Sales Down 6%
Pfizer's Viagra recorded a 6 percent sales decline, to $466 million worldwide. It wasn't just foreign currency headwinds: The decline was 14 percent in international sales and 1 percent in the U.S. Until now, Viagra has been an almost unstoppable growth machine for Pfizer. The company regularly put the price...
UPDATED: What Agencies Need to Know About Pfizer's Viagra Account
Any agency pitching Pfizer's Viagra account may want to bear the following in mind: The patent on Viagra expires somewhere between June 2011 and March 2012, which is when the client will likely end its ad budget for the brand. by Jim Edwards
Pfizer Rep Claims Zoloft Touted for Failed Cheerleaders; Viagra for Women
Former Pfizer sales rep Blair Collins' whistleblower lawsuit contains a detailed guide to how some of Pfizer's reps allegedly promoted their drugs. Among the tactics they allegedly used were recommending the antidepressant Zoloft for girls who failed to make the cheerleading squad; and staging talks in which doctors recommended prescribing...
Pfizer Rep Alleges Viagra Promoted With Unapproved Materials: "Get Those Things Cleaned Up!"
Blair Collins, a former Pfizer sales rep who received $2.4 million as one of the whistleblowers in the $2.3 billion Bextra settlement, alleged that reps used unapproved studies and pricing sheets to promote Viagra, among other drugs. by Jim Edwards
Pfizer's Foreign Viagra Ads: Mailman Jokes; Space Sperm and the Fountain of Youth
Pfizer has been criticized before -- once by the FDA -- for advertising Viagra in a way that was too light-hearted for a drug intended to treat a medical condition. But that has not stopped the company commissioning a slew of entertaing ads in foreign countries. by Jim Edwards
Pfizer Q1: Worse Than It Looks; Even Viagra Is Flagging
Pfizer's Q1 2009 numbers are worse than they appear at first glance. An accounting maneuver makes the company look much more productive than it is; and sales of its key franchises are weak -- even Viagra, down 1 percent, seems to have reached its peak. by Jim Edwards
Pfizer Probes Release of Viagra Boxer Shorts to Irish Doctors
Pfizer has launched an "internal investigation" into how a bunch of promotional Viagra boxer shorts ended up being sent to doctors in Ireland. by Jim Edwards
Rexahn, Vivus Believe the World Needs 2 More ED Drugs
Two companies are developing new erectile dysfunction drugs, even though there's already three on the market and one of those -- Pfizer's Viagra -- is set to go generic between 2011 and 2013. Rexahn is developing a compound called Zoraxel and Vivus is developing Avanafil. Rexahn is...
Swiss Allege Price Fixing on Viagra and Cialis
Swiss authorities have accused Pfizer and Eli Lilly of conspiring to fix prices for Viagra and Cialis. The news has created the best Bloomberg headline ever: "Pfizer, Lilly, Bayer Operated Erection-Drug Cartel, Swiss Say." A couple of days ago BNET noted that Pfizer and Lilly appear to...
Pfizer, Lilly Have Won the ED War; Bayer Wilts
Pfizer and Eli Lilly appear to have definitively won the erectile dysfunction war: their respective brands, Viagra and Cialis, both showed sales growth in Q4 2008 and for the full year. Lilly's growth was slightly faster, but it is coming off a smaller base. Bayer's brand, Levitra,...
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes


